NDUFB10

NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 · O96000 · NDUFB10 on Sugi Atlas →

3,132 patent compounds predicted against NDUFB10, 1,912 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Auraptene Auraptene (SCHEMBL2535029) 1.00 5/20
Auraptene Auraptene (SCHEMBL2535034) 1.00 5/20
SCHEMBL8491443 SCHEMBL8491443 0.56 4/20
SCHEMBL8489900 SCHEMBL8489900 0.52 4/20
SCHEMBL8489907 SCHEMBL8489907 0.52 4/20
SCHEMBL8492838 SCHEMBL8492838 0.52 4/20
SCHEMBL8492845 SCHEMBL8492845 0.52 4/20
SCHEMBL8489902 SCHEMBL8489902 0.51 4/20
SCHEMBL8489908 SCHEMBL8489908 0.51 4/20
SCHEMBL8491154 SCHEMBL8491154 0.51 4/20
SCHEMBL8491160 SCHEMBL8491160 0.51 4/20
SCHEMBL8491619 SCHEMBL8491619 0.50 4/20
SCHEMBL8491624 SCHEMBL8491624 0.50 4/20
SCHEMBL8491634 SCHEMBL8491634 0.50 4/20
7-Prenyloxycoumarin 7-Prenyloxycoumarin (SCHEMBL4898255) 0.79 3/20
SCHEMBL712741 SCHEMBL712741 0.57 3/20
Geiparvarin Geiparvarin (SCHEMBL2532495) 0.56 3/20
SCHEMBL6267768 SCHEMBL6267768 0.55 3/20
SCHEMBL8493191 SCHEMBL8493191 0.55 3/20
SCHEMBL1095981 SCHEMBL1095981 0.55 3/20

Clinical trials — most relevant to NDUFB10 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease PHASE3COMPLETED
Effect of Montelukast Versus Co Enzyme in Sepsis PHASE2/PHASE3COMPLETED
A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients PHASE3COMPLETED
Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease PHASE3COMPLETED
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder PHASE2WITHDRAWN
Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease PHASE2COMPLETED
Parkinson's Disease Treatment With Coenzyme Q10 PHASE2COMPLETED
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy PHASE2ACTIVE_NOT_RECRUITING
Ubiquinol (Reduced COQ10) for Patients With Sepsis PHASE2COMPLETED
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease PHASE1/PHASE2COMPLETED
An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)? PHASE1UNKNOWN
Bioavailability of Ubiquinone and Ubiquinol in Older Adults PHASE1COMPLETED
Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine nanCOMPLETED
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) nanRECRUITING
Nicotinamide Riboside and Mitochondrial Biogenesis nanCOMPLETED
The Natural History of Mitochondrial Diseases nanRECRUITING
Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome. nanUNKNOWN
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes nanNOT_YET_RECRUITING
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability. nanUNKNOWN
Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders nanCOMPLETED
Concentration of MitoQ in Human Skeletal Muscle nanUNKNOWN
Assessment of Follicular Fluid Level of Coenzyme Q10 in Women Undergoing ICSI nanUNKNOWN
Coenzyme Q10 Plus NADH Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis nanCOMPLETED
Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy nanRECRUITING
Fasting Tolerance in MCADD-infants nanUNKNOWN
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular Powerhouse) Dysfunction nanCOMPLETED
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a NDUFB10 binder may also engage these)

ProteinNameSimilarity
P0CC02 1.000 P0CC02 →
Q0MQF2 1.000 Q0MQF2 →
Q02373 1.000 Q02373 →
Q9DCS9 0.999 Q9DCS9 →
Q0MQF3 0.999 Q0MQF3 →
P0CC01 0.998 P0CC01 →
Q1HPL8 0.991 Q1HPL8 →
P90789 0.980 P90789 →
Q8RWA7 0.977 Q8RWA7 →
Q02368 0.977 Q02368 →
Q3E7A4 0.977 Q3E7A4 →
Q9CR61 0.976 Q9CR61 →
A8P488 0.976 A8P488 →
B3LG81 0.976 B3LG81 →
O49313 0.975 O49313 →
Q02772 0.975 Q02772 →
Q0UWF1 0.975 Q0UWF1 →
Q28GG4 0.975 Q28GG4 →
Q6CDV7 0.975 Q6CDV7 →
Q17Q91 0.974 Q17Q91 →
Q6BY05 0.974 Q6BY05 →
Q24276 0.974 Q24276 →
Q9ULR0 0.974 Q9ULR0 →
Q59QC6 0.974 Q59QC6 →
B5X171 0.974 B5X171 →
B3MGU5 0.973 B3MGU5 →
B6HEJ5 0.973 B6HEJ5 →
Q0MQE2 0.973 Q0MQE2 →
Q2M2S5 0.973 Q2M2S5 →
Q6BVY9 0.973 Q6BVY9 →